Skye Bioscience, Inc. (SKYE) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
SKYE Revenue Growth
SKYE Revenue Analysis (2014–2025)
As of May 8, 2026, Skye Bioscience, Inc. (SKYE) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, SKYE's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including ATAI (+811.8% YoY), and SNDL (+1.1% YoY). Compare SKYE vs ATAI →
SKYE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| SKYECurrent | $0 | - | - | - | |
 ATAI | $308,000 | +811.8% | - | -33341.2% | |
 SNDL | $946M | +1.1% | +73.1% | -0.5% |
SKYE Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $-723,352 | - | $-58,163,565 | - |
| 2024 | $0 | - | $0 | - | $-30,192,718 | - |
| 2023 | $0 | - | $0 | - | $-34,735,173 | - |
| 2022 | $0 | - | $0 | - | $-18,311,732 | - |
| 2021 | $0 | - | $0 | - | $-7,847,714 | - |
| 2020 | $0 | - | $-1,872 | - | $-6,289,013 | - |
| 2019 | $0 | - | $-1,462 | - | $-6,633,000 | - |
| 2018 | $0 | - | $-1,544 | - | $-4,693,000 | - |
| 2017 | $0 | - | $-8,038 | - | $-3,859,000 | - |
| 2016 | $0 | - | $-14,916 | - | $-4,471,000 | - |
See SKYE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs SKYE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare SKYE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonSKYE — Frequently Asked Questions
Quick answers to the most common questions about buying SKYE stock.
Is SKYE's revenue growth accelerating or slowing?
SKYE TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is SKYE's long-term revenue growth rate?
Skye Bioscience, Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is SKYE's revenue distributed by segment?
SKYE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.